Quality of Life the Danish Multiple Myeloma Patients (QoL-MM)
Quality of Life in Danish Multiple Myeloma Patients
Sponsor: Danish Myeloma Study Group
Listed as NCT02892383, this observational or N/A phase trial focuses on Multiple Myeloma and Quality of Life and remains completed. Sponsored by Danish Myeloma Study Group, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Oct 2024 — Sep 2025 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Mar 2022 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Recruiting
-
Apr 2019 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Apr 2017 — Oct 2017 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Apr 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Danish Myeloma Study Group
- Odense University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .